Abbott India warns of laxatives shortage in tussle with Goa regulator

Abbott Laboratories' Indian unit has warned of potential supply shortages of two popular laxative syrups, Cremaffin and Duphalac, after production was prohibited in India's Goa state. The two laxative brands have estimated annual sales of $70 million in India.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news